GAP1 Xenograft Project and the GAP1 Unique TMAs Project
Movember's Global Action Plan (GAP) prostate cancer biomarker initiative
Movember has released a global “Expression of Interest” to identify and engage interested researchers with relevant expertise in these two research areas:
- The Prostate Cancer Xenograft Project
Investigators interested in the GAP1 Xenograft project should email Movember at xenografts@movember.com and note that the EOI closes at 5pm on the 1st February 2013. - The Unique Prostate Cancer Tissue microarray (TMA) Project
Investigators interested in the GAP1 Unique TMA’s project should email Movember at tmas@movember.com and note that the EOI closes at 5pm on the 28th February 2013.
The information received during the EOI process will be used to create trans-national multi-disciplinary teams who will collaborate to answer key clinical questions.
